公开(公告)号：EP1492538A1

公开(公告)日：2005-01-05

申请号：EP03714899.6

申请日：2003-03-28

申请人： Boehringer Ingelheim International GmbH

发明人： MATSUI, Mayumi ,  OHKI, Toshimitsu ,  WADA, Koichi

IPC分类号： A61K31/5415 ,  A61K9/02 ,  A61P29/00 ,  A61P19/02 ,  A61K47/10

CPC分类号： A61K9/0031 ,  A61K31/542

摘要： The present invention relates to a suppository essentially consisting of the active ingredient meloxicam or a pharmaceutically acceptable salt thereof and at least one pharmaceutically acceptable excipient.

公开(公告)号：EP1448204A1

公开(公告)日：2004-08-25

申请号：EP02802290.3

申请日：2002-10-08

申请人： Boehringer Ingelheim International GmbH

发明人： WADA, Koichi ,  NAKATANI, Manabu ,  OHKI, Toshimitsu ,  TOYOSHIMA, Kenzo

IPC分类号： A61K31/55 ,  A61K9/00 ,  A61K9/14 ,  A61K9/20 ,  A61K47/26 ,  A61P11/02 ,  A61P11/06 ,  A61P27/02

CPC分类号： A61K9/0095 ,  A61K9/2018 ,  A61K31/55

摘要： The present invention refers to a new formulation of epinastine in form of a powder (dry syrup) to be mixed with water prior to use. Epinastine can be used either as free base or as a pharmaceutically acceptable salt thereof. Epinastine among others is for treating allergies, pain, in particular chronic pain and inflammation caused pain, migraine, asthma, rhinitis, conjunctivitis and/or bronchitis. In particular, the formulation is for treating allergies, dermatitis, rhinitis, conjunctivitis, bronchitis and asthma.